FIELD: ophthalmology.
SUBSTANCE: invention relates to ophthalmology and is intended to predict the effectiveness of the treatment of neovascular form of age-related macular degeneration (nAMD). In a patient with nAMD, the level of IL-8 and FGFβ is determined in the vitreous body sample, and if the level of IL-8 is equal to or more than 22.9 pg/ml, and/or FGFβ is equal to or more than 10.8 pg/ml, predict adverse response to anti-VEGF therapy.
EFFECT: invention provides determination of an adequate therapeutic strategy for nAMD.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING UNFAVORABLE RESPONSE TO ANTI-VEGF THERAPY FOR MACULAR NEOVASCULARIZATION BASED ON INTRAOCULAR PRESSURE INDICATORS | 2023 |
|
RU2810941C1 |
| METHOD OF PREDICTING AN UNFAVORABLE RESPONSE TO ANTI-VEGF THERAPY IN MACULAR NEOVASCULARIZATION BASED ON BLOOD PRESSURE PARAMETERS | 2023 |
|
RU2810940C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE RESPONSE TO ANTI-VEGF THERAPY IN MACULAR NEOVASCULARISATION BY BODY MASS INDEX | 2023 |
|
RU2821261C1 |
| METHOD OF PREDICTING RESPONSE TO ANTI-VEGF THERAPY IN MACULAR NEOVASCULARIZATION | 2023 |
|
RU2810939C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF MYOPIC CHOROIDAL NEOVASCULARIZATION AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN MYOPIC EYES | 2020 |
|
RU2749120C1 |
| METHOD OF TREATING EYE DISEASES | 2015 |
|
RU2722643C2 |
| METHOD FOR TREATMENT OF EYE DISEASES | 2015 |
|
RU2771900C2 |
| METHOD FOR SELECTING THERAPEUTIC APPROACH TO AGE-RELATED MACULAR DEGENERATION (AMD) | 2018 |
|
RU2707955C1 |
| COMBINED METHOD FOR TREATING CHOROIDAL NEOVASCULATION OF ALL TYPES | 2021 |
|
RU2770745C1 |
| METHOD FOR PREDICTING RESPONSE TO REPEATED ANTI-VEGF THERAPY IN CHOROIDAL NEOVASCULARIZATION IN AMD | 2022 |
|
RU2788971C1 |
